News

  • Leiden Bio Science Park makes its mark at BIO 2024

    At BIO International Convention in Boston, biotech ambition turns into partnership and progress. This year, Leiden Bio Science Park joined the Dutch delegation at the Netherlands Pavilion, right alongside innovators, investors, and policymakers all working to shape the future of…

  • EMA Visits Leiden Bio Science Park

    EMA visited Leiden Bio Science Park to explore how regulatory tools can better support early-stage innovation. The visit connected EMA representatives with local leaders across academia, investment, and biotech development for a forward-looking exchange on speeding therapies to patients.

  • Leiden collaboration enhances drug discovery for membrane proteins

    A joint effort between Leiden University’s Professor Ubbink’s lab and ZoBio’s Assay Development and Screening team has advanced fragment-based drug discovery targeting membrane proteins. Supported by a Dutch Research Council (NWO) AES grant, the project utilized protein-lipid nanodiscs to study…

  • LUMC develops vaccine to unmask hidden lung cancer cells

    Researchers at Leiden University Medical Center (LUMC), in collaboration with Erasmus MC and the Oncode Institute, have developed a novel vaccine targeting non-small cell lung cancer (NSCLC). This vaccine aims to expose cancer cells that have evaded the immune system,…

  • TechTalk- Women’s Health

    The May TechTalk at Leiden Bio Science Park focused on women’s health as a key driver of innovation, featuring expert insights on cardiology, diagnostics, early development, and maternal care. The event sparked lasting conversations and a shared call for more…

  • Life Sciences Café – Hollandbio komt naar je toer

    The latest Life Sciences Café at Leiden Bio Science Park highlighted AI in mental health, animal-free dairy innovation, and early liver disease detection. Co-hosted with hollandbio, the event showcased pioneering startups and celebrated the strength of the local life sciences…